“We ordered this robot as the COVID-19 pandemic was emerging in China and Europe, with the objective to be first to evaluate this technology in Canada. An automated system can potentially improve patient safety, as well as protect hospital personnel,” says Dr. Bruce Mazer, Executive Director and Chief Scientific Officer (CSO) of the RI-MUHC (Interim). “The robot was delivered at the RI-MUHC on Monday April 27, and will be tested in one patient room and one operating room at the RI-MUHC Centre for Innovative Medicine at the Glen site. We will also take this opportunity to assess if it can be used to disinfect stretchers and N-95 masks.”
